| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225975.2 |
Bicalutamide |
Esophageal cancer |
0.036825731 |
Resistant |
| ENSG00000225975.2 |
Bicalutamide |
Brain lower grade glioma |
0.016843183 |
Resistant |
| ENSG00000225975.2 |
Bicalutamide |
Lung squamous cell carcinoma |
0.008873084 |
Resistant |
| ENSG00000225975.2 |
Bicalutamide |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019183155 |
Resistant |
| ENSG00000225975.2 |
Bicalutamide |
Breast invasive carcinoma |
0.048170222 |
Sensitive |
